Surrogate markers aid lung cancer trials

Research suggests that surrogate markers for overall survival are acceptable endpoints for clinical trials of chemotherapy and radiotherapy in patients with lung cancer.
Source: MedWire News - Lung Cancer - Category: Cancer & Oncology Source Type: news